Research

Packages

Life of the unit

Next seminars

Last publications

Updated

Validation of the French translation-adaptation of the Impact of Cancer version 2 (IOCv2) questionnaire on a breast cancer survivors population

Auteurs

• Blanchin Myriam - Ingénieur de recherche en Biostatistique  - Université de Nantes - UFR de Pharmacie 
  
  
• Dauchy Sarah
  
  
• Cano Alejandra
  
  
• Brédart Anne
  
  
• Aaronson Neil
  
  
• Hardouin Jean-Benoit - Maitre de Conférences - HDR - Biostatistique  - UFR de Pharmacie 
  
  

Description

Nature : Articles dans une revue internationale
Thématique : Biostatistique et Mesures Subjectives en Santé
Rang : Rang A : publication porté par un membre de l'unité, dans le cadre de l'unité
Axe de recherche principal: Validation d'échelles

Blanchin M, Dauchy S, Cano A, Brédart A, Aaronson N, Hardouin JB (2015) Validation of the French translation-adaptation of the Impact of Cancer version 2 (IOCv2) questionnaire on a breast cancer survivors population. Health and Quality of Life Outcomes, 13: 110.

Lien

Abstract

Background The Impact of Cancer version 2 (IOCv2) was designed to assess the physical and psychosocial health experience of cancer survivors through its positive and negative impacts. Although the IOCv2 is available in English and Dutch, it has not yet been validated for use in French-speaking populations. The current study was undertaken to provide a comprehensive assessment of the reliability and validity of the French language version of the IOCv2 in a sample of breast cancer survivors. Methods An adapted French version of the IOCv2 as well as demographic and medical information were completed by 243 women to validate the factor structure divergent/divergent validities and reliability. Concurrent validity was assessed by correlating the IOCv2 scales with measures from the SF-12, PostTraumatic Growth Inventory and Fear of Cancer Recurrence Inventory. Results The French version of the IOCv2 supports the structure of the original version, with four positive impact dimensions and four negative impact dimensions. This result was suggested by the good fit of the confirmatory factor analysis and the adequate reliability revealed by Cronbach's alpha coefficients and other psychometric indices. The concurrent validity analysis revealed patterns of association between IOCv2 scale scores and other measures. Unlike the original version, a structure with a Positive Impact domain consisting in the IOCv2 positive dimensions and a Negative Impact domain consisting in the negative ones has not been clearly evidenced in this study. The limited practical use of the conditional dimensions Employment Concerns and Relationship Concerns, whether the patient is partnered or not, did not make possible to provide evidence of validity and reliability of these dimensions as the subsets of sample to work with were not large enough. The scores of these conditional dimensions have to be used with full knowledge of the facts of this limitation of the study. Conclusions Integrating IOCv2 into studies will contribute to evaluate the psychosocial health experience of the growing population of cancer survivors, enabling better understanding of the multi-dimensional impact of cancer.

Projet(s) ayant donné lieu à cette publication

VALIOC : Adaptation et validation en français du questionnaire Impact Of Cancer (IOCv2)

Publications ayant le même axe principal de recherche (Validation d'échelles)

• Teigné D, Mabileau G, Anthoine E, Lucas M, Leclère B, Moret L, Terrien N (2019) Transcultural adaptation and psychometric study of the French version of the nursing home survey on patient safety culture questionnaire. BMC Health Serv Res, 19(1): 490.
  
  
• Larramendy-Magnin S, Anthoine E, L'Heude B, Leclère B, Moret L (2019) Refining the medical student safety attitudes and professionalism survey (MSSAPS): adaptation and assessment of patient safety perception of French medical residents. BMC Med Educ, 19(1): 222.
  
  
• Barais M, Laporte C, Schuers M, Saint-Lary O, Frappé P, Dibao-Dina C, Darmaun D, Bouchez T, Gelly J (2018) Cross-sectional multicentre study on the cohort of all the French junior lecturers in general practice. Eur J Gen Pract, 24(1): 99-105.
  
  
• Perrot B, Anthoine E, Hardouin JB (2018) Validscale : A Stata module to validate measurement scales. Stata Journal, 18(1): 29-50.
  
  
• Dany A, Rapin A, Lavallart B, Saoüt V, Reveillère C, Bassez G, Tiffreau V, Péréon Y, Sacconi S, Eymard B, Dramé M, Jolly D, Novella JL, Hardouin JB, Boyer F (2017) The quality of life in genetic neuromuscular disease questionnaire: Rasch validation of the French version.. Muscle Nerve, 56(6): 1085-1091.
  
  
• Fossum P, Le Meur G, Couret C, Pechereau A, Hode F, Albert F, Anthoine E, Lebranchu P (2017) Validation of the French version of the health-related quality of life questionnaire for adult strabismus (AS-20). J Fr Ophtalmol, 40(9): 738-743.
  
  
• Baayen C, Feuillet F, Clermidi P, Crétolle C, Sarnacki S, Podevin G, Hardouin JB (2017) Validation of the French versions of the Hirschsprung’s disease and Anorectal malformations Quality of Life (HAQL) questionnaires for adolescents and adults. Health and Quality of Life Outcomes, 15: 24.
  
  
• Boutoleau-Bretonnière C, Evrard C, Hardouin JB, Rocher L, Charriau T, Etcharry-Bouyx F, Auriacombe M, Richard-Mornas A, Lebert F, Pasquier F, Sauvaget A, Bulteau S, Vercelletto M, Derkinderen P, Boutoleau-Bretonnière C, Thomas R (2015) DAPHNE: a new tool for diagnosis of behavioral variant of frontototemporal dementia. Dement Geriatr Cogn Dis Extra, 5(3): 503-516.
  
  
• Dany A, Barbe C, Morrone I, Wolak A, Reveillère C, Hardouin JB, Dramé M, Sacconi S, Bassez G, Tiffreau V, Richard I, Gallais B, Jolly D, Novella JL, Boyer F (2015) Construction of a Quality of Life Questionnaire for Slowly Progressive Neuromuscular Disease. Quality of Life Research, 24(11): 2615–2623 .
  
  
• Panouillères M, Anota A, Nguyen T, Brédart A, Bosset J, Monnier A, Mercier M, Hardouin JB (2014) Evaluation properties of the French version of the OUT-PATSAT35 satisfaction with care questionnaire according to classical and item response theory analyses. Quality of life Research, 23(7): 2089-2101.
  
  
• Anthoine E, Coutherut J, Delmas C, Moret L (2014) Development and psychometric testing of a scale assessing the sharing of medical information and interprofessional communication: the CSI scale. BMC Health Service Research, 13: 14:126.
  
  
• Moret L, Anthoine E, Aubert- Wastiaux H, Le Rhun M, Leux C, Mazereeuw-Hautier J, Stalder J, Barbarot S (2013) TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents.. PLoS One, 8(10): e76493.
  
  
• Clermidi P, Podevin G, Crétolle C, Sarnacki S, Hardouin JB (2013) The challenge of measuring quality of life for children with Hirschsprung's diseases or anorectal malformations. Journal of Pediatric Surgery, 48(10): 2118-2127.
  
  

Publications liées à l'axe principal de recherche (Validation d'échelles)

• Challet G, Hardouin JB, Boutin C, Gorwood P, Le Bourvellec JD, Feuillet F, Vénisse JL, Grall-Bronnec M (2014) A shorter and multidimensional version of the Gambling Attitudes and Beliefs and Survey (GABS-23). Journal of Gambling Studies , 30(2): 349-367.
  
  
• Grall-Bronnec M, Challet G, Sébille V, Gorwood P, Boutin C, Vénisse JL, Hardouin JB (2012) A French adaptation of the Gambling Related Cognitions Scale (GRCS): A useful tool for assessment of irrational thoughts among gamblers. Journal of Gambling Issues, 27: 1-21.
  
  
• Hardouin JB, Mesbah M (2008) Selection of items fitting a Rasch model. In Mathematical methods for survival analysis, reliability and Quality of life (Eds Huber C., Limnios N., Mesbah M., Nikulin M.): Hermes: Paris. Chapter 17: 255-274..
  
  
• Hardouin JB (2005) Construction d'échelles d'items unidimensionnelles en qualité de vie. Thèse de doctorat de l'Université René Descartes - Paris 5, 201.
  
  
• Hardouin JB, Mesbah M (2004) Clustering Binary Variables in Subscales using an Extended Rasch model and Akaike Information Criterion. Communication in Statistics – Theory and Methods, 33(6): 1277-1294.